Skip to content

Clinical trials

Completed Leukemia, Biphenotypic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Biphenotypic, Acute Status: Completed Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
20014
20024
20036
20044
20057
20064
20077
20087
20095
20103
20115
20121
20133
20146
20154
20165
20173
20181
20191
20201
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed121

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center16
National Cancer Institute (NCI)13
Memorial Sloan Kettering Cancer Center9
Children's Oncology Group7
M.D. Anderson Cancer Center7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Case Comprehensive Cancer Center4
Northwestern University4
Wake Forest University Health Sciences4
Asan Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Biphenotypic, Acute121
Precursor Cell Lymphoblastic Leukemia-Lymphoma102
Leukemia, Myeloid, Acute89
Leukemia65
Leukemia, Lymphocytic, Chronic, B-Cell64
Burkitt Lymphoma58
Leukemia, Myelomonocytic, Chronic56
Blast Crisis54
Leukemia, Myeloid, Accelerated Phase54
Leukemia, Myeloid, Chronic-Phase54

Trials

Showing 76 to 100 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.